Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Current Protocols in Neuroscience|April 23, 2008
Using phage display in neurobiologyAndrew Bradbury, Daniele Sblaterro, Roberto Marzari, et al.
Wilhelm Roux'S Archives of Developmental Biology|March 18, 2017
Low variability of the protein species synthesized byDrosophila melanogaster embryosAdriano Savoini, Fulvio Micali, Roberto Marzari, et al.
Genome Research|May 3, 2003
Selecting open reading frames from DNAPaola Zacchi, Daniele Sblattero, Fiorella Florian, et al.
Arthritis and Rheumatism|March 30, 2007
Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in ratsFabio Fischetti, Paolo Durigutto, Paolo Macor, et al.
Investigational New Drugs|August 18, 2010
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibodyGiorgio Zauli, Federica Corallini, Sonia Zorzet, et al.
European Journal of Immunology|June 23, 2005
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59Federica Ziller, Paolo Macor, Roberta Bulla, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 4, 2009
Profiling the autoantibody repertoire by screening phage-displayed human cDNA librariesRoberto Di Niro, Sara D'Angelo, Paola Secco, et al.
Cancer Research|November 3, 2007
In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximabPaolo Macor, Claudio Tripodo, Sonia Zorzet, et al.
European Journal of Immunology|October 2, 2002
The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studiesRoberto Marzari, Daniele Sblattero, Paolo Macor, et al.
The Biochemical Journal|February 22, 2005
Characterizing monoclonal antibody epitopes by filtered gene fragment phage displayRoberto Di Niro, Fortunato Ferrara, Tarcisio Not, et al.
Pageof 4